Genito-Urinary
Genito-Urinary
We’re here for you. Call us at 844-346-7222 or
find a clinical trial
If you have any questions or are interested in participating in one of our Clinical Trials, please take note of the associated protocol number and contact our team at (201) 518-3587, or email us at email.
16
Clinical Trials
Genito-Urinary
Phase III
Accepting Patients
nct/study# NCT04241185 / MK-3475-992-005
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Clinical Trial To Study The Efficacy And Safety Of Pembrolizumab (MK-3475) In Combination With Chemoradiotherapy (CRT) Versus CRT Alone In Participants With Muscle-Invasive Bladder Cancer (MIBC) (KEYNOTE-992)
Learn More
Genito-Urinary
Ib/II
Pending
nct/study# NCT03869190 / WO39613 - Morpheus Urothelial
Phase Ib/II, Open-Label, Multicenter, Randomized Umbrella Study Evaluating The Efficacy And Safety Of Multiple Immunotherapy-Based Treatment Combinations In Patients With Urothelial Carcinoma (Morpheus-UC).
Learn More
Genito-Urinary
Phase III
Accepting Patients
nct/study# NCT03244384 / A031501-JTCC
Phase III Randomized Adjuvant Study Of Pembrolizumab In Muscle Invasive And Locally Advanced Urothelial Carcinoma (AMBASSADOR) Versus Observation
Learn More
Genito-Urinary
Phase II
Accepting Patients
nct/study# NCT03117309 / CRN-GU16-260
Phase II Study Of Front Line Therapy With Nivolumab And Salvage Nivolumab + Ipilimumab In Patients With Advanced Renal Cell Carcinoma. HCRN: GU16-260
Learn More
Genito-Urinary
Phase II
Accepting Patients
nct/study# NCT04289779 / GU18-343
A Phase 2 Study Of Cabozantinib In Combination With Atezolizumab As Neoadjuvant Treatment For Muscle-Invasive Bladder Cancer (ABATE)
Learn More
Genito-Urinary
Phase II
Accepting Patients
nct/study# NCT02625961 / MK-3475-057
A Phase II Clinical Trial To Study The Efficacy And Safety Of Pembrolizumab (MK-3475) In Subjects With High Risk Non-Muscle Invasive Bladder Cancer (NMIBC) Unresponsive To Bacillus Calmette-Guerin (BCG) Therapy
Learn MoreWe are here for you
For more information or to schedule an appointment, call (844) 346-7222. You can also schedule an appointment by calling the RCCA location nearest you.
Regional Cancer Care Associates is one of fewer than 200 medical practices in the country selected to participate in the Oncology Care Model (OCM); a recent Medicare initiative aimed at improving care coordination and access to and quality of care for Medicare beneficiaries undergoing chemotherapy treatment.